NCT02854501View on ClinicalTrials.gov

Second Trimester Maternal Serum Homocysteine Levels and Uterine Artery Doppler for Prediction of Preeclampsia and Placentation Disorders

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Preeclampsia
All Listed Sponsors
lead

Cairo University

OTHER

NCT02854501 - Second Trimester Maternal Serum Homocysteine Levels and Uterine Artery Doppler for Prediction of Preeclampsia and Placentation Disorders | Biotech Hunter | Biotech Hunter